Allen JE - Search Results

1

Role of Dopamine Receptors in the Anticancer Activity of ONC201.

Kline CLB, Ralff MD, Lulla AR, Wagner JM, Abbosh PH, Dicker DT, Allen JE, El-Deiry WS. Kline CLB, et al. Among authors: allen je. Neoplasia. 2018 Jan;20(1):80-91. doi: 10.1016/j.neo.2017.10.002. Epub 2017 Dec 5. Neoplasia. 2018. PMID: 29216597 Free PMC article.

2

Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.

Allen JE, Hart LS, Dicker DT, Wang W, El-Deiry WS. Allen JE, et al. Cancer Biol Ther. 2009 Nov;8(22):2194-205. doi: 10.4161/cbt.8.22.10450. Epub 2009 Nov 27. Cancer Biol Ther. 2009. PMID: 19923899 Free PMC article.

3

Circulating Tumor Cells and Colorectal Cancer.

Allen JE, El-Deiry WS. Allen JE, et al. Curr Colorectal Cancer Rep. 2010 Oct 1;6(4):212-220. doi: 10.1007/s11888-010-0069-7. Curr Colorectal Cancer Rep. 2010. PMID: 20890370 Free PMC article.

4

Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.

Mayes PA, Dolloff NG, Daniel CJ, Liu JJ, Hart LS, Kuribayashi K, Allen JE, Jee DI, Dorsey JF, Liu YY, Dicker DT, Brown JM, Furth EE, Klein PS, Sears RC, El-Deiry WS. Mayes PA, et al. Among authors: allen je. Cancer Res. 2011 Aug 1;71(15):5265-75. doi: 10.1158/0008-5472.CAN-11-1383. Epub 2011 Jun 6. Cancer Res. 2011. PMID: 21646472 Free PMC article.

5

Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting.

Faltas B, Zeidan A, Peters K, Das A, Joudeh J, Navaraj A, Dolloff NG, Harvey HA, Jiang Y, Allen JE, Dicker DT, El Deiry WS. Faltas B, et al. Among authors: allen je. J Clin Oncol. 2011 Jul 20;29(21):2946-7; author reply 2947-8. doi: 10.1200/JCO.2011.36.6179. Epub 2011 Jun 20. J Clin Oncol. 2011. PMID: 21690466 No abstract available.

6

Oxaliplatin uses JNK to restore TRAIL sensitivity in cancer cells through Bcl-xL inactivation.

Allen JE, El-Deiry WS. Allen JE, et al. Gastroenterology. 2011 Aug;141(2):430-4. doi: 10.1053/j.gastro.2011.06.026. Epub 2011 Jun 23. Gastroenterology. 2011. PMID: 21699898 No abstract available.

7

Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents.

Wang W, Gallant JN, Katz SI, Dolloff NG, Smith CD, Abdulghani J, Allen JE, Dicker DT, Hong B, Navaraj A, El-Deiry WS. Wang W, et al. Among authors: allen je. Cancer Biol Ther. 2011 Aug 1;12(3):229-38. doi: 10.4161/cbt.12.3.17033. Epub 2011 Aug 1. Cancer Biol Ther. 2011. PMID: 21725212

8

Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer.

Gallant JN, Allen JE, Smith CD, Dicker DT, Wang W, Dolloff NG, Navaraj A, El-Deiry WS. Gallant JN, et al. Among authors: allen je. Cancer Biol Ther. 2011 Aug 1;12(3):239-51. doi: 10.4161/cbt.12.3.17034. Epub 2011 Aug 1. Cancer Biol Ther. 2011. PMID: 21725213

9

Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases.

Patel AS, Allen JE, Dicker DT, Peters KL, Sheehan JM, Glantz MJ, El-Deiry WS. Patel AS, et al. Among authors: allen je. Oncotarget. 2011 Oct;2(10):752-60. doi: 10.18632/oncotarget.336. Oncotarget. 2011. PMID: 21987585 Free PMC article.

10

Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes.

Allen JE, Ferrini R, Dicker DT, Batzer G, Chen E, Oltean DI, Lin B, Renshaw MW, Kretz-Rommel A, El-Deiry WS. Allen JE, et al. Mol Cancer Ther. 2012 Oct;11(10):2087-95. doi: 10.1158/1535-7163.MCT-12-0366. Epub 2012 Jul 16. Mol Cancer Ther. 2012. PMID: 22802267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

568 results

Search Page